BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 16007607)

  • 21. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
    Morland BJ; Shaw PJ
    Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
    Veerman AJ; Hählen K; Kamps WA; Van Leeuwen EF; De Vaan GA; Solbu G; Suciu S; Van Wering ER; Van der Does-Van der Berg A
    J Clin Oncol; 1996 Mar; 14(3):911-8. PubMed ID: 8622039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
    Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
    Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Tubergen DG; Krailo MD; Meadows AT; Rosenstock J; Kadin M; Morse M; King D; Steinherz PG; Kersey JH
    J Clin Oncol; 1995 Jun; 13(6):1368-76. PubMed ID: 7751881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies.
    Vecchi V; Aricò M; Basso G; Ceci A; Madon E; Mandelli F; Masera G; Massimo L; Pession A; Zanesco L
    Cancer; 1993 Oct; 72(8):2517-24. PubMed ID: 8402470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ
    J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
    Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65 Suppl 1():83-7. PubMed ID: 6948610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Lauer SJ; Camitta BM; Leventhal BG; Mahoney DH; Shuster JJ; Adair S; Casper JT; Civin CI; Graham M; Kiefer G
    Cancer; 1993 May; 71(9):2854-61. PubMed ID: 8467463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment results of T-cell acute lymphoblastic leukemia therapy in children from 1983-1985].
    Kubiczek K; Rytlewska M; Pituch-Noworolska A
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):273-5. PubMed ID: 7808950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [L-asparaginase-induced hyperlipidemia in a case of acute lymphoblastic leukemia].
    Konya H; Tamura S; Miyazaki E; Inoue N; Okamoto T; Takemoto Y; Kohsaki M; Kanemaru A; Kakishita E
    Rinsho Ketsueki; 1991 Mar; 32(3):250-4. PubMed ID: 2041167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curing children with leukemia in West Virginia.
    Ritchey AK; Starling KA; Keller FG; Martin J; Steiner ME; Defazio J
    W V Med J; 1997; 93(4):179-81. PubMed ID: 9274141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
    Kudva GC; Chandy M; Raghupathy P; Dennison D; Srivastava A; Bhushan V; Singh R
    Indian J Cancer; 1994 Jun; 31(2):78-85. PubMed ID: 7927453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Outcome of treatment protocol 8704T for childhood T cell leukemia and lymphoma].
    Horibe K; Katayama I; Miyajima Y; Matsumoto K; Fukuda M; Yoshida J; Kudo K; Kato K; Kojima S; Matsuyama T
    Rinsho Ketsueki; 1994 Jul; 35(7):657-64. PubMed ID: 8065018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Rivera GK; Hudson MM; Liu Q; Benaim E; Ribeiro RC; Crist WM; Pui CH
    Blood; 1996 Aug; 88(3):831-7. PubMed ID: 8704238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results and complications of induction treatment of acute leukemia in children. A personal series of 79 cases (1988-1989)].
    Regaieg R; Bertrand Y; Mardini R; Manel AM; Berthier JC; Magaud JP; Charrin C; Barbe G; Souillet G; Philippe N
    Pediatrie; 1992; 47(1):47-53. PubMed ID: 1337777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased thrombin generation during fibrinogen and platelet recovery as an explanation for hypercoagulability in children with L-asparaginase therapy for ALL or NHL: a preliminary report.
    Korte W; Feldges A; Baumgartner C; Ullmann S; Niederer V; Schmid L
    Klin Padiatr; 1994; 206(4):331-3. PubMed ID: 7967434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute lymphoblastic leukemia in childhood: treatment, results and prognostic factors.
    Advani SH; Giri NK; Pai SK; Nair CN; Kurkure PA; Tapan SK; Gopal R; Nadkarni KS; Pai VR; Muzumdar AT
    Indian J Cancer; 1989 Sep; 26(3):180-8. PubMed ID: 2630428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
    Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
    J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dental complication involving Pseudomonas during chemotherapy for acute lymphoblastic leukemia.
    Cheatham BD; Henry RJ
    J Clin Pediatr Dent; 1994; 18(3):215-7. PubMed ID: 8054308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.